Amgen Inc (AMGN)

230.98
+4.99(+2.21%)
  • Volume:
    2,489,777
  • Day's Range:
    227.74 - 231.87
  • 52 wk Range:
    198.64 - 258.45

AMGN Overview

Prev. Close
225.99
Day's Range
227.74-231.87
Revenue
26.32B
Open
229.96
52 wk Range
198.64-258.45
EPS
11.89
Volume
2,489,777
Market Cap
123.56B
Dividend (Yield)
7.76
(3.43%)
Average Volume (3m)
2,609,600
P/E Ratio
20.80
Beta
0.56
1-Year Change
6.04%
Shares Outstanding
534,930,850
Next Earnings Date
Nov 01, 2022
What is your sentiment on Amgen?
or
Market is currently closed. Voting is open during market hours.

Amgen Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Amgen Inc Analysis

Amgen Inc Company Profile

Amgen Inc Company Profile

Employees
24300

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Analyst Price Target

Average249.81 (+7.88% Upside)
High295
Low182
Price231.57
No. of Analysts28
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuySellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellNeutral
SummaryStrong BuyStrong BuyStrong BuyStrong SellNeutral